Related references
Note: Only part of the references are listed.High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival
Diane K. Birks et al.
NEURO-ONCOLOGY (2011)
Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors
Diane K. Birks et al.
BRAIN PATHOLOGY (2010)
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing
Rintaro Hashizume et al.
NEURO-ONCOLOGY (2010)
Clinical and Pathological Features of Paediatric Malignant Rhabdoid Tumours
Daniel A. Morgenstern et al.
PEDIATRIC BLOOD & CANCER (2010)
Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma
Jason L. Hornick et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
Eric M. Jackson et al.
CLINICAL CANCER RESEARCH (2009)
Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions
Xiao-Ping Zou et al.
HUMAN PATHOLOGY (2009)
Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
Susan N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience
Paola Fidani et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Cribriform Neuroepithelial Tumor (CRINET): A Nonrhabdoid Ventricular Tumor With INI1 Loss and Relatively Favorable Prognosis
Martin Hasselblatt et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System A Meta-Analysis of Observational Studies
Uma H. Athale et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors
Sharon L. Gardner et al.
PEDIATRIC BLOOD & CANCER (2008)
Germline mutation of INI1/SMARCB1 in familial schwannomatosis
Theo J. M. Hulsebos et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P. Cahill et al.
CLINICAL CANCER RESEARCH (2007)
hSNFS/INII-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities
F. Bourdeaut et al.
JOURNAL OF PATHOLOGY (2007)
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma
W. Mueller et al.
ONCOGENE (2007)
Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype
Christine Haberler et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Characterization of glioblastomas in young adults
B. K. Kleinschmidt-DeMasters et al.
BRAIN PATHOLOGY (2006)
Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoit tumors (AT/RT) of childhood
J Mühlisch et al.
ONCOGENE (2006)
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation
MS Isakoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair
E Cannavo et al.
CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor
MA Zimmerman et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy
TM Tekautz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms
AR Judkins et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry
JM Hilden et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system
SB Wharton et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Long-term sequelae in children treated for brain tumors: Impairments, disability, and handicap
M Macedoni-Luksic et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2003)
No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors
F Zhang et al.
GENES CHROMOSOMES & CANCER (2002)
Share Paper
